http://www.sciencedaily.com/news/health_medicine/vaccines/ News on vaccines including HPV vaccine, shingles vaccine, bird flu vaccines and more. Read the latest research on vaccination risks and complications. en-us Sat, 26 May 2012 14:05:01 EDT Sat, 26 May 2012 14:05:01 EDT 60 http://www.sciencedaily.com/images/logosmall.gif http://www.sciencedaily.com/news/health_medicine/vaccines/ For more science articles, visit ScienceDaily. http://www.sciencedaily.com/releases/2012/05/120523115047.htm Scientists have successfully protected laboratory animals from lethal hantavirus disease using a novel approach that combines DNA vaccines and duck eggs. Wed, 23 May 2012 11:50:50 EDT http://www.sciencedaily.com/releases/2012/05/120523115047.htm http://www.sciencedaily.com/releases/2012/05/120522152653.htm Antibodies that help to stop the HIV virus have been found in breast milk. Researchers have isolated the antibodies from immune cells called B cells in the breast milk of infected mothers in Malawi, and showed that the B cells in breast milk can generate neutralizing antibodies that may inhibit the virus that causes AIDS. Tue, 22 May 2012 15:26:26 EDT http://www.sciencedaily.com/releases/2012/05/120522152653.htm http://www.sciencedaily.com/releases/2012/05/120522134946.htm Getting a flu shot during pregnancy provides unanticipated benefits to the baby, according to the authors of a large population-based study examining the issue. Specifically, the study showed that H1N1 vaccination during the pandemic was associated with a significantly reduced risk of stillbirth, preterm birth and extremely small babies at birth. Tue, 22 May 2012 13:49:49 EDT http://www.sciencedaily.com/releases/2012/05/120522134946.htm http://www.sciencedaily.com/releases/2012/05/120521163745.htm The pandemic 2009 H1N1 vaccine can generate antibodies in vaccinated individuals not only against the H1N1 virus, but also against other influenza virus strains including H5N1 and H3N2. This discovery adds an important new dimension to the finding last year that people infected with pandemic 2009 H1N1 virus produced high levels of antibodies that were broadly cross-reactive against a variety of flu strains. Mon, 21 May 2012 16:37:37 EDT http://www.sciencedaily.com/releases/2012/05/120521163745.htm http://www.sciencedaily.com/releases/2012/05/120516174437.htm Biologists have succeeded in engineering algae to produce potential candidates for a vaccine that would prevent transmission of the parasite that causes malaria. Wed, 16 May 2012 17:44:44 EDT http://www.sciencedaily.com/releases/2012/05/120516174437.htm http://www.sciencedaily.com/releases/2012/05/120509135943.htm Vaccines remain the best line of defense against deadly pathogens and now medical researchers are using clever functional screening methods to attempt to speed new vaccines into production that are both safer and more potent. Wed, 09 May 2012 13:59:59 EDT http://www.sciencedaily.com/releases/2012/05/120509135943.htm http://www.sciencedaily.com/releases/2012/05/120508103927.htm Researchers have found a potential way to develop universal flu vaccines and eliminate the need for seasonal flu vaccinations. Tue, 08 May 2012 10:39:39 EDT http://www.sciencedaily.com/releases/2012/05/120508103927.htm http://www.sciencedaily.com/releases/2012/05/120507131953.htm A long-term follow-up analysis of participants in the Step Study, an international HIV-vaccine trial, has confirmed that certain subgroups of male study participants were at higher risk of becoming infected after receiving the experimental vaccine compared to those who received a placebo. The vaccine used in the study did not contain the HIV virus, but it did contain HIV genes which were delivered to cells using a vector that employed a type of cold virus known as adenovirus serotype 5 (Ad5). Mon, 07 May 2012 13:19:19 EDT http://www.sciencedaily.com/releases/2012/05/120507131953.htm http://www.sciencedaily.com/releases/2012/05/120504172103.htm The proportion of insured girls and young women completing the human papillomavirus (HPV) vaccine among those who initiated the series has dropped significantly -- as much as 63 percent -- since the vaccine was approved in 2006, according to new research. Fri, 04 May 2012 17:21:21 EDT http://www.sciencedaily.com/releases/2012/05/120504172103.htm http://www.sciencedaily.com/releases/2012/05/120502143852.htm After a marathon debate over a pair of studies that show how the avian H5N1 influenza virus could become transmissible in mammals, and an unprecedented recommendation by a government review panel to block publication, one of the studies was finally and fully published on May 3, 2012. Wed, 02 May 2012 14:38:38 EDT http://www.sciencedaily.com/releases/2012/05/120502143852.htm http://www.sciencedaily.com/releases/2012/04/120423131344.htm A vaccine expert, pediatrician refute three common myths about child vaccine safety. Mon, 23 Apr 2012 13:13:13 EDT http://www.sciencedaily.com/releases/2012/04/120423131344.htm http://www.sciencedaily.com/releases/2012/04/120423104949.htm The herpes zoster vaccine, also known as the shingles vaccine, is generally safe and well tolerated according to a Vaccine Safety Datalink study of 193,083 adults. Mon, 23 Apr 2012 10:49:49 EDT http://www.sciencedaily.com/releases/2012/04/120423104949.htm http://www.sciencedaily.com/releases/2012/04/120422162219.htm A new potential vaccine carrier may extend the shelf life of and aid in the stockpiling of critical vaccines. A new microemulsion has been found to be both stable and a good candidate for delivering a variety of antigens. Sun, 22 Apr 2012 16:22:22 EDT http://www.sciencedaily.com/releases/2012/04/120422162219.htm http://www.sciencedaily.com/releases/2012/04/120418135130.htm Scientists are reporting development and successful testing in laboratory mice of a substance that shows promise for becoming the first antidote for cocaine toxicity in humans. The new so-called "passive vaccine" reversed the motor impairment, seizures and other dangerous symptoms of a cocaine overdose, which claims thousands of lives each year among users of the illicit drug. Wed, 18 Apr 2012 13:51:51 EDT http://www.sciencedaily.com/releases/2012/04/120418135130.htm http://www.sciencedaily.com/releases/2012/04/120417113418.htm A new brain cancer vaccine tailored to individual patients by using material from their own tumors has proven effective in a multicenter phase 2 clinical trial at extending their lives by several months or longer. The patients suffered from recurrent glioblastoma multiforme —- which kills thousands of Americans every year. Tue, 17 Apr 2012 11:34:34 EDT http://www.sciencedaily.com/releases/2012/04/120417113418.htm http://www.sciencedaily.com/releases/2012/04/120411144318.htm This study for the first time shows what dengue virus region the immune system of humans target when they are fighting off the virus. Wed, 11 Apr 2012 14:43:43 EDT http://www.sciencedaily.com/releases/2012/04/120411144318.htm http://www.sciencedaily.com/releases/2012/04/120411102715.htm When swine flu struck Sweden in 2009, it was clear that certain age groups were more vulnerable than others. An epidemiologist is now planning to study immunity against influenza in children. Wed, 11 Apr 2012 10:27:27 EDT http://www.sciencedaily.com/releases/2012/04/120411102715.htm http://www.sciencedaily.com/releases/2012/04/120405224651.htm A new study shows how worries over vaccine risks can allow preventable contagious diseases, such as measles and whooping cough, to make a comeback. Thu, 05 Apr 2012 22:46:46 EDT http://www.sciencedaily.com/releases/2012/04/120405224651.htm http://www.sciencedaily.com/releases/2012/04/120405131425.htm The discovery of how a vital immune cell recognizes dead and damaged body cells could modernize vaccine technology by "tricking" cells into launching an immune response, leading to next-generation vaccines that are more specific, more effective and have fewer side-effects. Thu, 05 Apr 2012 13:14:14 EDT http://www.sciencedaily.com/releases/2012/04/120405131425.htm http://www.sciencedaily.com/releases/2012/04/120404210013.htm Researchers have gained important clues about immune system responses that could play a role in protecting people from HIV infection in follow-up studies from the world's largest HIV vaccine trial to date. Wed, 04 Apr 2012 21:00:00 EDT http://www.sciencedaily.com/releases/2012/04/120404210013.htm http://www.sciencedaily.com/releases/2012/04/120404210003.htm Insights into how the first vaccine ever reported to modestly prevent HIV infection in people might have worked were recently published. Wed, 04 Apr 2012 21:00:00 EDT http://www.sciencedaily.com/releases/2012/04/120404210003.htm http://www.sciencedaily.com/releases/2012/04/120404102951.htm Asthma is a chronic inflammatory and respiratory disease caused by an abnormal reactivity to allergens in the environment. Of the several avenues of exploration that are currently being developed, vaccination appears to be the most promising approach. Scientists have now revealed an innovative vaccine against one of the allergens most frequently encountered in asthma patients. Wed, 04 Apr 2012 10:29:29 EDT http://www.sciencedaily.com/releases/2012/04/120404102951.htm http://www.sciencedaily.com/releases/2012/04/120403193735.htm An intranasal vaccine that includes four weakened strains of influenza could do a better job in protecting children from the flu than current vaccines, new research shows. Tue, 03 Apr 2012 19:37:37 EDT http://www.sciencedaily.com/releases/2012/04/120403193735.htm http://www.sciencedaily.com/releases/2012/04/120403140034.htm Younger girls are more likely than adult women to report side effects after receiving Gardasil, the human papillomavirus vaccine. The side effects are non-serious and similar to those associated with other vaccines, according to a new study. Tue, 03 Apr 2012 14:00:00 EDT http://www.sciencedaily.com/releases/2012/04/120403140034.htm http://www.sciencedaily.com/releases/2012/04/120402094316.htm The characterization of a rare immune cell's involvement in antibody production and ability to "remember" infectious agents could help to improve vaccination and lead to new treatments for immune disorders. Mon, 02 Apr 2012 09:43:43 EDT http://www.sciencedaily.com/releases/2012/04/120402094316.htm http://www.sciencedaily.com/releases/2012/04/120402094150.htm Stem cells had greater effect than differentiated tumor cells in eliciting antitumor immunity in vivo. Antibodies and T cells targeted cancer stem cells in laboratory models. Data could provide a rationale for a new type of immune therapy. Mon, 02 Apr 2012 09:41:41 EDT http://www.sciencedaily.com/releases/2012/04/120402094150.htm http://www.sciencedaily.com/releases/2012/04/120402094146.htm Vaccines for measles were not associated with an increased risk of febrile seizures among 4-6 year olds during the six weeks after vaccination, according to a new study. Mon, 02 Apr 2012 09:41:41 EDT http://www.sciencedaily.com/releases/2012/04/120402094146.htm http://www.sciencedaily.com/releases/2012/03/120329225052.htm Women who have been infected by two different strains of HIV from two different sexual partners – a condition known as HIV superinfection – have more potent antibody responses that block the replication of the virus compared to women who’ve only been infected once. Thu, 29 Mar 2012 22:50:50 EDT http://www.sciencedaily.com/releases/2012/03/120329225052.htm http://www.sciencedaily.com/releases/2012/03/120329101301.htm Researchers are closing in on a needle-free vaccine for respiratory syncytial virus (RSV), a major cause of respiratory illness in children under two years of age. Thu, 29 Mar 2012 10:13:13 EDT http://www.sciencedaily.com/releases/2012/03/120329101301.htm http://www.sciencedaily.com/releases/2012/03/120328090822.htm The vaccination against human papillomavirus (HPV) reduces the risk of a renewed HPV-associated illness in patients who have already had diseases as a consequence of an HPV infection new research suggests. It had previously been the view that the HPV vaccination had a purely preventative effect and was also only effective in young women and men. Wed, 28 Mar 2012 09:08:08 EDT http://www.sciencedaily.com/releases/2012/03/120328090822.htm http://www.sciencedaily.com/releases/2012/03/120321152642.htm While researchers say that vaccines for intestinal infections are among the most difficult to develop, a recent discovery may provide the critical information needed for success. "Sometimes atomic structure gives us clues on how viruses work and how to make better vaccines," said one of the researchers. Wed, 21 Mar 2012 15:26:26 EDT http://www.sciencedaily.com/releases/2012/03/120321152642.htm http://www.sciencedaily.com/releases/2012/03/120321105331.htm Australia's prolonged whooping cough epidemic has entered a disturbing new phase, with a study showing a new strain or genotype may be responsible for the sharp rise in the number of cases. Wed, 21 Mar 2012 10:53:53 EDT http://www.sciencedaily.com/releases/2012/03/120321105331.htm http://www.sciencedaily.com/releases/2012/03/120314183348.htm A coalition of three health groups has released new guidelines for the prevention and early detection of cervical cancer. The guidelines generally advise a reduction in the number of tests women get over their lifetime to better ensure that they receive the benefits of testing while minimizing the harms. Wed, 14 Mar 2012 18:33:33 EDT http://www.sciencedaily.com/releases/2012/03/120314183348.htm http://www.sciencedaily.com/releases/2012/03/120308174929.htm Scientists have discovered that blocking PD-1, an immune molecule that inhibits the immune response to viral infections, can have a significant effect on HIV-like illness in non-human primates. Thu, 08 Mar 2012 17:49:49 EST http://www.sciencedaily.com/releases/2012/03/120308174929.htm http://www.sciencedaily.com/releases/2012/03/120308174809.htm Mutations in HIV that develop during the first few weeks of infection may play a critical role in undermining a successful early immune response, a finding that reveals the importance of vaccines targeting regions of the virus that are less likely to mutate. Thu, 08 Mar 2012 17:48:48 EST http://www.sciencedaily.com/releases/2012/03/120308174809.htm http://www.sciencedaily.com/releases/2012/03/120307185131.htm Scientists have developed a vaccine that has protected nonhuman primates against multiple exposures to simian immunodeficiency virus (SIV) given in three clusters over more than three years. SIV is the nonhuman primate version of HIV. Wed, 07 Mar 2012 18:51:51 EST http://www.sciencedaily.com/releases/2012/03/120307185131.htm http://www.sciencedaily.com/releases/2012/03/120306073011.htm Recent research found that microneedle vaccine patches are more effective at delivering protection against influenza virus in mice than subcutaneous or intramuscular inoculation. A new, detailed analysis of the early immune responses helps explain why the skin is such fertile ground for vaccination with these tiny, virtually painless microneedles. Tue, 06 Mar 2012 07:30:30 EST http://www.sciencedaily.com/releases/2012/03/120306073011.htm http://www.sciencedaily.com/releases/2012/03/120306073007.htm In the controversy surrounding the newly developed strains of avian H5N1 flu viruses, scientists and policy makers are struggling with one question in particular: what level of biosafety is best for studying these potentially lethal strains of influenza? Experts now argue their different views of how to safely handle H5N1 flu viruses. Tue, 06 Mar 2012 07:30:30 EST http://www.sciencedaily.com/releases/2012/03/120306073007.htm http://www.sciencedaily.com/releases/2012/02/120228114304.htm Scientists have discovered a new "off switch" in our immune response which could be boosted in diseases caused by over-activation of our immune system, or blocked to improve vaccines. Tue, 28 Feb 2012 11:43:43 EST http://www.sciencedaily.com/releases/2012/02/120228114304.htm http://www.sciencedaily.com/releases/2012/02/120227111536.htm Scientists have found that an emerging class of long-lasting flu vaccines called "universal" vaccines could for the first time allow for the effective, wide-scale prevention of flu by limiting the virus' ability to spread and mutate. A computational model showed that the vaccines could achieve unprecedented control of the flu virus both seasonally and during outbreaks of highly contagious new strains. Mon, 27 Feb 2012 11:15:15 EST http://www.sciencedaily.com/releases/2012/02/120227111536.htm http://www.sciencedaily.com/releases/2012/02/120223103918.htm The debate about the potential severity of an outbreak of airborne H5N1 influenza in humans needs to move on from speculation and focus instead on how we can safely continue H5N1 research and share the results among researchers, according to experts. Thu, 23 Feb 2012 10:39:39 EST http://www.sciencedaily.com/releases/2012/02/120223103918.htm http://www.sciencedaily.com/releases/2012/02/120216095040.htm Researchers have made the discovery of a vaccine that will potentially help combat hepatitis C. Thu, 16 Feb 2012 09:50:50 EST http://www.sciencedaily.com/releases/2012/02/120216095040.htm http://www.sciencedaily.com/releases/2012/02/120214100940.htm New research shows how the malaria parasite changes into a banana shape before sexual reproduction, a finding that could provide targets for vaccine or drug development and may explain how the parasite evades the human immune system. Tue, 14 Feb 2012 10:09:09 EST http://www.sciencedaily.com/releases/2012/02/120214100940.htm http://www.sciencedaily.com/releases/2012/02/120213134142.htm Scientists have tested a new 'therapeutic vaccine' against HIV on volunteers. The participants were 'so to say' vaccinated with their own cells. The immune system of the testees was better than before in attacking and suppressing the virus, the scientists have reported. Mon, 13 Feb 2012 13:41:41 EST http://www.sciencedaily.com/releases/2012/02/120213134142.htm http://www.sciencedaily.com/releases/2012/02/120201092725.htm A medical researcher has developed a cancer vaccine that can prolong the life expectancy of patients with pancreatic cancer. Now he is testing a new vaccine that hopefully is able to kill all types of cancer cells. Wed, 01 Feb 2012 09:27:27 EST http://www.sciencedaily.com/releases/2012/02/120201092725.htm http://www.sciencedaily.com/releases/2012/01/120131092748.htm Researchers have identified key peptides that could lead to a universal vaccine for influenza and would activate alternative mechanisms of the immune system. They have discovered a series of peptides, found on the internal structures of influenza viruses that could lead to the development of a universal vaccine for influenza, one that gives people immunity against all strains of the disease, including seasonal, avian, and swine flu. Tue, 31 Jan 2012 09:27:27 EST http://www.sciencedaily.com/releases/2012/01/120131092748.htm http://www.sciencedaily.com/releases/2012/01/120130093649.htm The vaccines of the future against infections, influenza and cancer can be administered using an electrical pulse and a specially produced DNA code, new research suggests. The DNA code programs the body's own cells to produce a super-fast missile defense against the disease, researchers say. Mon, 30 Jan 2012 09:36:36 EST http://www.sciencedaily.com/releases/2012/01/120130093649.htm http://www.sciencedaily.com/releases/2012/01/120129151005.htm Genetics has provided surprising insights into why vaccines used in both the UK and US to combat serious childhood infections can eventually fail. The study, which investigates how bacteria change their disguise to evade the vaccines, has implications for how future vaccines can be made more effective. Sun, 29 Jan 2012 15:10:10 EST http://www.sciencedaily.com/releases/2012/01/120129151005.htm http://www.sciencedaily.com/releases/2012/01/120127162749.htm Influenza virus can rapidly evolve from one form to another, complicating the effectiveness of vaccines and anti-viral drugs used to treat it. By first understanding the complex host cell pathways that the flu uses for replication, researchers are finding new strategies for therapies and vaccines, according to a new study. Fri, 27 Jan 2012 16:27:27 EST http://www.sciencedaily.com/releases/2012/01/120127162749.htm http://www.sciencedaily.com/releases/2012/01/120127140526.htm Scientists have developed a new vaccine to treat cancer at the pre-clinical level. They developed a new approach for treating the disease based on manipulating the immune response to malignant tumors. Fri, 27 Jan 2012 14:05:05 EST http://www.sciencedaily.com/releases/2012/01/120127140526.htm http://www.sciencedaily.com/releases/2012/01/120122152536.htm Researchers have created synthetic nanoparticles that target lymph nodes and greatly boost vaccine responses. Sun, 22 Jan 2012 15:25:25 EST http://www.sciencedaily.com/releases/2012/01/120122152536.htm http://www.sciencedaily.com/releases/2012/01/120111134045.htm Promoting immunizations as a part of routine office-based medical practice is needed to improve adult vaccination rates, a highly effective way to curb the spread of diseases across communities, prevent needless illness and deaths, and lower health care costs, according to a new study. Wed, 11 Jan 2012 13:40:40 EST http://www.sciencedaily.com/releases/2012/01/120111134045.htm http://www.sciencedaily.com/releases/2012/01/120105142449.htm A national U.S. clinical trial testing the efficacy of a novel brain tumor vaccine has begun. The vaccine will be tested in patients with newly diagnosed glioblastoma multiforme (GBM), the most aggressive and highest grade malignant glioma. Thu, 05 Jan 2012 14:24:24 EST http://www.sciencedaily.com/releases/2012/01/120105142449.htm http://www.sciencedaily.com/releases/2012/01/120104174816.htm New research points investigators toward finding a genital herpes vaccine that works on both viruses that cause disease. Wed, 04 Jan 2012 17:48:48 EST http://www.sciencedaily.com/releases/2012/01/120104174816.htm http://www.sciencedaily.com/releases/2012/01/120104135406.htm The rotavirus vaccine was pulled from the marketplace in 1999 after being associated with painful gastrointestinal complications, however, the updated rotavirus vaccines do not appear to increase the occurrence of these potentially fatal side effects, according to a new study by child health experts. Wed, 04 Jan 2012 13:54:54 EST http://www.sciencedaily.com/releases/2012/01/120104135406.htm http://www.sciencedaily.com/releases/2012/01/120104134802.htm New vaccine research in monkeys suggests that scientists are homing in on the critical ingredients of a protective HIV vaccine and identifies new HIV vaccine candidates to test in human clinical trials. Wed, 04 Jan 2012 13:48:48 EST http://www.sciencedaily.com/releases/2012/01/120104134802.htm http://www.sciencedaily.com/releases/2011/12/111222152021.htm The flu shot, typically the first line of defense against seasonal influenza, could better treat the US population, thanks to new research. Thu, 22 Dec 2011 15:20:20 EST http://www.sciencedaily.com/releases/2011/12/111222152021.htm http://www.sciencedaily.com/releases/2011/12/111221151713.htm One of the most vexing challenges in the battle against dengue virus, a potentially fatal mosquito-borne virus, is that getting infected once can put people at greater risk for a more severe infection down the road. A new study details how the interaction between a person's immune response and a subsequent dengue infection could mean the difference between getting a mild fever and going into fatal circulatory failure. Wed, 21 Dec 2011 15:17:17 EST http://www.sciencedaily.com/releases/2011/12/111221151713.htm http://www.sciencedaily.com/releases/2011/12/111220133701.htm A new candidate malaria vaccine has the potential to neutralize all strains of the most deadly species of malaria parasite. Tue, 20 Dec 2011 13:37:37 EST http://www.sciencedaily.com/releases/2011/12/111220133701.htm http://www.sciencedaily.com/releases/2011/12/111216112907.htm Statins, traditionally known as cholesterol-lowering drugs, may reduce mortality among patients hospitalized with influenza, according to a new study. Fri, 16 Dec 2011 11:29:29 EST http://www.sciencedaily.com/releases/2011/12/111216112907.htm